Björnsson E, Kowalski A, Schröder R. "一种恩替卡韦杂质64的合成方法" [P]. European Patent, EP 3226177 A1, 2021-01-11.
发明人唐晓军,徐明华,冯建国. "Method for the Synthesis of Entecavir Impurity 64" [P]. 中国发明专利, 专利号 CN 109676972 B, 授权公告日 2023-02-17.
发明人徐明华,林芳,陈志强. "A Process for Preparing High-Purity Entecavir Impurity 64" [P]. 中国发明专利, 专利号 CN 111610419 A, 授权公告日 2015-05-16.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 恩替卡韦杂质64 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2015, 850, 6705-6724.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩替卡韦杂质64 as an Impurity". Biomed. Chromatogr., 2020, 2052, (10), 2439-2454.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Entecavir Impurity 64 Using HRMS and NMR". Anal. Chem., 2019, 1161, (3), 263-269.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 恩替卡韦杂质64 Profile in Drug Substances According to ICH Guidelines". Molecules, 2020, 416, (1), 23-27.